Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Adani Enterprises may hit Rs 67, like Sun Pharma: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that Adani Enterprises may hit Rs 67 and likes Sun Pharma.

    • Buy Engineers India; sell Sun TV, Bharat Financial: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Engineers India and sell Sun TV and Bharat Financial Inclusion.

    • Sun Pharma may move to Rs 750: Vijay Chopra

      Vijay Chopra of enochventures.com feels that Sun Pharmaceutical Industries may move to Rs 750.

    • Buy SBI, ICICI Bank, TCS, Infosys, Sun Pharma: VK Sharma

      VK Sharma, Head Private Broking & Wealth Management at HDFC Securities recommends buying State Bank of India, ICICI Bank, TCS, Infosys and Sun Pharma.

    • Sell Marico, buy Sun Pharma Advanced Research: Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, one can sell Marico and buy Sun Pharma Advanced Research Company.

    • Short ACC, buy Sun Pharmaceutical Industries: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one can short ACC and buy Sun Pharmaceutical Industries.

    • Cement, pharma and banks look attractive: Tulsian

      The demonetization of Rs 500 and rs 1,000 notes couple with Donald Trump‘s victory in US presidential elections make sectors like pharma, cement, NBFC and banks a good bet, said SP Tulsian of SP Tulsian.com.

    • Pharma stocks gain post Clinton's loss: Sun, Dr Reddy‘s up 5%

      Stocks like Dr Reddy's and Sun Pharma gained around 5 percent on Wednesday. Major Indian pharma companies earn around 15-50 percent revenue from the US market.

    • Buy, sell, hold: Kickstart your week with these 10 stocks

      Bank of America Merrill Lynch maintains buy on Lupin with regulatory overhang over valuations should recede post Goa Establishment Inspection Report (EIR). Goa plant accounts for over 50 percent of current supplies to US. It believes the stock should re-rate driven by near-term catalysts and due to faster ramp-up in Gavis portfolio.

    • Gaurang Shah positive on Sun Pharmaceutical Industries

      Gaurang Shah of Geojit BNP Paribas is positive on Sun Pharmaceutical Industries.

    • Positive on ITC & ICICI Bank, says Deven Choksey

      In an interview to CNBC-TV18, Deven Choksey, MD of KRChoksey Investment Managers Private Limited shared his readings and outlook on specific stocks and sectors.

    • Buy Sun Pharma 700 Put, Ashok Leyland 92.5 Call: VK Sharma

      VK Sharma, Head Private Broking & Wealth Management at HDFC Securities recommends buying Sun Pharma 700 Put and Ashok Leyland 92.5 Call.

    • See 5-6% downside in OMCs including HPCL, BPCL: Rahul Mohindar

      Rahul Mohindar of viratechindia.com is of the view that one may see 5-6 percent downside in OMCs including HPCL and BPCL.

    • Diwali rocket stocks: 10 large caps to buy in Samvat 2073

      ICICI Direct sees Sensex EPS to grow 16.4 percent YoY to Rs 1600 in FY17 and then witness growth of 17.5 percent YoY in FY18 to Rs 1880. It has set a one year forward target of 31000 for the Sensex and 9400 for the Nifty.

    • Buy L&T Fin, Sun Pharma; sell RComm on every rise: Rudramurthy

      CA Rudramurthy BV of Vachana Investments recommends buying L&T Finance Holdings and Sun Pharma and advises selling RComm on every rise.

    • Buy Petronet LNG; sell Sun Pharma, Axis Bank: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Petronet LNG and sell Sun Pharma and Axis Bank.

    • Bull's Eye: Buy Just Dial; sell Glenmark, TVS Motor, Siemens

      Sameet Chavan of Angel Broking recommends buying Just Dial with a target of Rs 492 and sell Glenmark Pharma with a target of Rs 860.

    • Stay invested in Sun Pharma: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that one may stay invested in Sun Pharmaceutical.

    • Buy Sun Pharma, Grasim, JSW Steel: Rahul Shah

      Rahul Shah of Motilal Oswal is of the view that one may buy Sun Pharmaceutical Industries, Grasim Industries and JSW Steel.

    • Buy, sell or hold: Focus on 8 largecap stocks for your portfolio

      Morgan Stanley is overweight on Maruti with target at Rs 5169/share as checks suggest that discounts have come off sequentially. It says leverage gains will offset forex headwinds. EBITDA margin should rise to 15.4 percent in Q2 from 14.8 percent in Q1 and expects compaby to post EBITDA of Rs 2780 crore and profit of Rs 1810 crore in Q2.

    • Glenmark should start performing, target Rs 980: Amit Gupta

      Amit Gupta of ICICIdirect is of the view that Glenmark Pharma should start performing with a traget of Rs 980.

    • See Sun Pharma move up, Infosys down; short Vedanta: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that Sun Pharma may move to Rs 900-950 while Infosys may move lower and drop below Rs 1000.

    • Buy Sun Pharma, IOC, Jain Irrigation Systems: Rahul Shah

      Rahul Shah of Motilal Oswal is of the view that one can buy Sun Pharma, Indian Oil Corporation and Jain Irrigation Systems.

    • Buy Bata India, Sun Pharma; sell Exide Industries: Rajat Bose

      Rajat Bose of rajatkbose.com is of the vie wthat one can buy Bata India and Sun Pharma and sell Exide Industries.

    • Bull's Eye: Buy Havells, Sun Pharma, Ceat, HPCL, Yes Bank

      Ruchit Jain of Angel Broking recommends buying Sun Pharma for target of Rs 808 and Havells India with target of Rs 447.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347